These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6619281)

  • 1. Determination of serum bactericidal activity with the aid of luminous bacteria.
    Barak M; Ulitzur S; Merzbach D
    J Clin Microbiol; 1983 Aug; 18(2):248-53. PubMed ID: 6619281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM; Bryan CS; Hawiger J; Colley DG
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of the phagocytosis mechanism with the aid of luminous bacteria.
    Barak M; Ulitzur S; Merzbach D
    J Med Microbiol; 1984 Aug; 18(1):65-72. PubMed ID: 6748042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of luminous bacteria for determination of phagocytosis.
    Barak M; Ulitzur S; Merzbach D
    J Immunol Methods; 1983 Nov; 64(3):353-63. PubMed ID: 6366060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of turkey complement with Escherichia coli isolated from turkeys.
    Ellis MG; Arp LH; Lamont SJ
    Am J Vet Res; 1989 Aug; 50(8):1285-9. PubMed ID: 2675694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
    Kochi SK; Johnson RC
    Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural hemolytic and bactericidal activities of sea bream Sparus aurata serum are effected by the alternative complement pathway.
    Sunyer JO; Tort L
    Vet Immunol Immunopathol; 1995 Apr; 45(3-4):333-45. PubMed ID: 7676614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
    Gardner SE; Anderson DC; Webb BJ; Stitzel AE; Edwards MS; Spitzer RE; Baker CJ
    Infect Immun; 1982 Mar; 35(3):800-8. PubMed ID: 6802760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bactericidal activity and induction of chemiluminescence of polymorphonuclear leukocytes: complement activation pathway requirements in defense against Neisseria meningitidis.
    Fredlund H; Sjöholm AG; Selander B; Holmström E; Olcén P; Danielsson D
    Int Arch Allergy Immunol; 1993; 100(2):135-43. PubMed ID: 8443467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F; Loos M
    Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.
    Takahashi M; Takahashi S; Brade V; Nussenzweig V
    J Clin Invest; 1978 Aug; 62(2):349-58. PubMed ID: 670397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.
    Odumeru JA; Wiseman GM; Ronald AR
    Infect Immun; 1985 Nov; 50(2):495-9. PubMed ID: 3876995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes.
    Heddle RJ; Knop J; Steele EJ; Rowley D
    Immunology; 1975 Jun; 28(6):1061-6. PubMed ID: 1093969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.
    Schreiber RD; Morrison DC; Podack ER; Müller-Eberhard HJ
    J Exp Med; 1979 Apr; 149(4):870-82. PubMed ID: 372483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis.
    Attridge SR; Qadri F; Albert MJ; Manning PA
    Clin Diagn Lab Immunol; 2000 May; 7(3):444-50. PubMed ID: 10799459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.
    Jarvis GA; Vedros NA
    Infect Immun; 1987 Jan; 55(1):174-80. PubMed ID: 3098684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bacterial reaction by the alternative pathway of complement: potentiation by target multiplicity and modulation by serum factors.
    Fietta A; Fortunato A; Dos Santos C; Grassi F; Siccardi AG
    Infect Immun; 1981 Sep; 33(3):704-9. PubMed ID: 6793516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.